| Name | Title | Contact Details |
|---|
Tevano Systems Holdings Inc., through its operating subsidiaries, is a technology company with custom and proprietary hardware and software technologies. Its subsidiary, Illuria Security, Inc. is an early-stage software development company whose technology involves active cyber deception to protect critical network systems of enterprise systems of all sizes. Using deception technology, Illuria`s software seeks to solve the challenge of cyber-attacks by detecting threats, systematically deceiving attackers, and actively deterring attacks. Its subsidiary Tevano Systems Inc. is the developer of Health Shield™, an AI-driven, electronic tablet that video displays a user with their body temperature and other information. It provides detailed reports of all scans done throughout an enterprise.
Every day the threats from cybercrime are evolving, meaning the traditional one-size-fits-all approach to cyber security risk management either results in too much or too little security.
Redgrave Strategic Data Solutions LLC (Redgrave Data) provides innovative and defensible technology strategies, insight, services, and solutions to clients who face electronically stored information challenges. Our goal is to reimagine how data is analyzed and used to drive effective business and legal solutions. With an approach that incorporates extensive machine learning and analytics experience, along with deep knowledge of various technologies and tools, including robotic process automation and data visualization, Redgrave Data tackles issues strategically, efficiently, and differently. Our services and experience are centered at the intersection of the law, technology, and science, and we advocate a multi-disciplinary approach to develop innovative pathways to navigate complex issues. When organizations desire to reduce risk and increase defensibility, Redgrave Data is positioned to offer solutions—including bespoke systems and expert analysis—that the competition cannot match. Redgrave Strategic Data Solutions, LLC (Redgrave Data) is an affiliated company of majority owner Redgrave LLP, a Delaware limited liability partnership. Redgrave LLP has no role in the day-to-day operations of Redgrave Data. Redgrave Data is not a law firm and does not provide legal services.
Dealer IT is a technology solutions partner for automotive dealers. We provide help desk, DMS, and CRM support, as well as vendor and IT management. With our technical support and proactive strategies, dealerships receive custom solutions for all of their IT needs. As a result, we help dealerships reduce expenses, run more efficiently, and grow in the long-term. Our 30 years of combined experience in the industry also allow us to design and implement solutions with our distinct customers in mind. Dealer IT was founded in 2011 by its now president, Travis M. Ingram. Since then, Travis has built his business by solving the need for IT leadership in the automotive industry. The company has grown to include over 20 automotive groups nationwide, who have all recognized the benefit of Dealer ITs innovative solutions.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.